Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/2/26 Senseonics (SENS) Gemini sensor for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
3/1/26 Merck & Co., Inc. (MRK) Welireg for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
3/1/26 Sanofi (SNY) Dupixent for Aspergillosis Subscribers Only Subscribers Only Subscribers Only
3/1/26 Sanofi (SNY) Dupixent for Asthma Subscribers Only Subscribers Only Subscribers Only
2/28/26 Merck & Co., Inc. (MRK) Welireg for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/30/2022 Subscribers Only Subscribers Only Trial Data - Updated Results
06/30/2022 Subscribers Only Subscribers Only Trial Data - Updated Results
06/30/2022 Subscribers Only Subscribers Only Trial Data - Updated Results
06/30/2022 Subscribers Only Subscribers Only Trial Data - Updated Results
10/22/2023 Subscribers Only Subscribers Only Trial Data - Updated Results